Roche Xeloda To Be Reimbursed By Medicare As Prodrug Of 5-FU
Roche's oral treatment for late-stage metastatic breast cancer Xeloda (capecitabine) will be covered for outpatient use by Medicare effective Jan. 1, 1999, the company announced Jan 13.
Roche's oral treatment for late-stage metastatic breast cancer Xeloda (capecitabine) will be covered for outpatient use by Medicare effective Jan. 1, 1999, the company announced Jan 13.